Coronary Revascularization Versus Conservative Therapy in Patients With Treated Critical Limb Ischemia — INCORPORATE  

Obstructive Coronary Artery Disease Clinical Trial

Official title: Intentional Coronary Revascularization Versus Conservative Therapy in Patients Undergoing Peripheral Artery Revascularization Due to Critical Limb Ischemia

Status Recruiting

Clinical Trial Summary

The objective of the INCORPORATE trial is to evaluate whether an intentional invasive strategy with ischemia targeted, reasonably complete coronary revascularization and optimal medical therapy is superior as compared to a primary conservative approach and optimal medical therapy alone in terms of spontaneous myocardial infarct-free and overall survival in patients with severe peripheral artery disease, underwent peripheral artery revascularization due to critical limb ischemia.

The INCORPORATE trial is designed to be non-blinded, open-label, prospective 1:1 randomized controlled multicentric trial.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Ischemia
• Myocardial Ischemia
• Obstructive Coronary Artery Disease

• NCT number: NCT03712644
• Study type: Interventional
• Source: Medical University of Graz
• Contact: Gabor G Toth, MD, PhD
• Phone: 004331638512544
• Email: gabor.g.toth@medunigraz.at
• Status: Recruiting
• Phase: N/A
• Start date: July 11, 2018
• Completion date: August 31, 2022